<DOC>
	<DOCNO>NCT01855607</DOCNO>
	<brief_summary>To assess whether six week treatment twice day topical Menthol application decrease persistent neuropathic pain chemotherapy among breast colorectal cancer patient .</brief_summary>
	<brief_title>Topical Menthol Treatment Chemotherapy Induced Peripheral Neuropathy</brief_title>
	<detailed_description>To assess whether six week treatment BID topical Menthol application decrease persistent neuropathic pain measure change Brief Pain Inventory-Short Form ( BPI-SF worst pain score ) , follow neoadjuvant/adjuvant chemotherapy taxanes oxaliplatin-based regimen among breast colorectal cancer patient .</detailed_description>
	<mesh_term>Menthol</mesh_term>
	<criteria>1 . Age &gt; 21 year 2 . History stage IIII breast colorectal cancer 3 . Patient complete adjuvant neoadjuvant Taxane base breast cancer therapy Oxaliplatin base colon cancer chemotherapy one 24 month prior registration 4 . Signed informed consent 5 . Concomitant biologic , hormonal radiation therapy acceptable . 6 . Narcotics , antidepressant medication treatment CIPN permit , patient stable dose least one month prior enrollment . 7 . Pain define BPI bad pain great equal 5 10 . 8 . CIPN define experience neuropathy ( numbness , tingle , thermal hyperalgesia cold allodynia ) hand foot frequently time past seven day . 1 . Previous treatment topical menthol ( menthol/methylsalicylate product like BenGay , Aspercreme , Icy Hot ) concentration within previous 3 month 2 . Known diabetic neuropathy 3 . Severe concomitant illnesses 4 . Known allergy preexist skin disease prohibits use menthol 5 . Any topical treatment neuropathy serious skin condition hand foot .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>chemotherapy induce neuropathy</keyword>
</DOC>